AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2014
Jan 31, 2014
34117_dirs_2014-01-31_99d991ed-6dcf-4dd5-81b7-1c1fc9246409.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2014-01-31
Reporting Person: KUMAR AMIT (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-01-31 | Common Stock | P | 50000 | $0.3969 | Acquired | 498804 | Direct |
| 2014-01-31 | Common Stock | P | 5000 | $0.42 | Acquired | 503804 | Direct |
| 2014-01-31 | Common Stock | P | 2500 | $0.4205 | Acquired | 506304 | Direct |
| 2014-01-31 | Common Stock | P | 2500 | $0.4209 | Acquired | 508804 | Direct |
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6